David Gomez-Almaguer
Overview
Explore the profile of David Gomez-Almaguer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
1228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lira-Lara O, Robles-Nasta M, Olivares-Gazca J, Kharfan-Dabaja M, Rivera-Alvarez M, Garcia-Velez D, et al.
Bone Marrow Transplant
. 2025 Mar;
PMID: 40069376
Autologous hematopoietic cell transplantation (aHSCT) is a viable therapeutic approach in patients with autoimmune diseases. Since June 2015, we have autografted on an outpatient basis 1700 aHSCT patients. The objective...
2.
Candelaria M, Villela L, Onate-Ocana L, Beltran B, Torres-Viera M, Oliver A, et al.
J Geriatr Oncol
. 2024 Nov;
16(1):102160.
PMID: 39615249
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma, predominantly afflicting older adults. There remains a notable absence of data regarding DLBCL in older adults...
3.
Colunga-Pedraza P, De la Garza-Salazar F, Vaquera-Alfaro H, Gomez-De Leon A, Bustillos-Munoz M, Tarin-Arzaga L, et al.
Br J Haematol
. 2024 Nov;
PMID: 39581951
Therapies such as corticosteroids, thrombopoietin receptor agonists and immunomodulators have been consistently under the spotlight in the search for a better treatment for immune thrombocytopenia (ITP). However, none of them...
4.
Colunga-Pedraza P, Vaquera-Alfaro H, Guzman-Martinez Z, Aleman-Jimenez M, Vega-Mateos A, Gomez-De Leon A, et al.
Ann Hematol
. 2024 Nov;
103(12):5607-5614.
PMID: 39562359
Up to one-third of patients with classical Hodgkin lymphoma (cHL) are not responsive to first-line therapy or eventually relapse. Immune checkpoint inhibitors (ICIs) have been successfully employed to treat relapsed/refractory...
5.
Reassessing blood product irradiation in haploidentical transplantation: a single-center perspective
Martinez-Hernandez J, Lopez-Mora Y, Salazar-Riojas R, Alvarado Navarro D, Hernandez-Navarro A, Chavez-Estrada Y, et al.
Hematology
. 2024 Oct;
29(1):2420144.
PMID: 39466074
Objectives: The main objective was to investigate the incidence of transfusion-associated graft-versus-host disease (TA-GVHD) in patients who underwent haploidentical hematopoietic cell transplants (HCT) and received non-irradiated leukoreduced blood components. The...
6.
Jaime-Perez J, Valdespino-Valdes J, Gomez-De Leon A, Barragan-Longoria R, Dominguez-Villanueva A, Cantu-Rodriguez O, et al.
Front Immunol
. 2024 Oct;
15:1400610.
PMID: 39430740
Background: Hematopoietic cell transplantation (HCT) increases survival for acute leukemia. Outpatient allogeneic HCT reduces costs and increases transplant rates in developing countries. We report outcomes of outpatient HLA-identical and haploidentical...
7.
Cantu-Rodriguez O, Hawing-Zarate J, Dorsey-Trevino E, Hernandez-Barajas D, Villalobos-Gutierrez L, Jaime-Perez J, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39337084
: The lactate/pyruvate (LP) ratio has been studied as an alternative to serum lactate to determine clinical prognosis. Despite its clinical utility, there is a paucity of evidence evaluating the...
8.
Jaime-Perez J, Gonzalez-Trevino M, Gomez-De Leon A, Campos-Bocardo M, Barragan-Longoria R, Cantu-Rodriguez O, et al.
Blood Cells Mol Dis
. 2024 Sep;
110:102886.
PMID: 39243657
No abstract available.
9.
Jaime-Perez J, Gonzalez-Trevino M, Gomez-De Leon A, Campos-Bocardo M, Barragan-Longoria R, Cantu-Rodriguez O, et al.
Blood Cells Mol Dis
. 2024 Aug;
109:102885.
PMID: 39182343
Objective: To document the results of outpatient hematopoietic stem cell transplantation (HSCT) from the peripheral blood (PB) of sibling donors without anti-thymocyte globulin (ATG) in the conditioning regimen. Material And...
10.
Solis-Armenta R, Rodriguez-Rodriguez S, Hernandez-Perez A, Paulina-Zapata N, Delgado N, Montano-Figueroa E, et al.
Ann Hematol
. 2024 Aug;
103(10):4089-4097.
PMID: 39177797
Acute myeloid leukemia (AML) is the most frequent indication for allogeneic hematopoietic cell transplantation (alloHCT) worldwide; social and health system barriers limit its access. We performed an observational retrospective analysis...